News

Regulatory affairsRegulatory Round-up - January 2026
Filter:AllPress ReleaseCell TherapiesGene TherapiesDigital and AutomationSpin-outs, Start-ups, Sector investmentManufacturingRegulatory affairsSkills and Training
Year:All2026202520242023 →
Regulatory News - April 2021Regulatory News - April 2021Regulatory news - March 2021Regulatory news - March 2021Regulatory news - February 2021Regulatory news - February 2021Regulatory News - January 2021Regulatory News - January 2021Regulatory News - December 2020Regulatory News - December 2020Regulatory News - November 2020Regulatory News - November 2020Press release: New data from Cell and Gene Therapy Catapult report shows move towards commercialisation and 48% increase in GMP manufacturing space despite COVID-19 pandemicPress release: New data from Cell and Gene Therapy Catapult report shows move towards commercialisation and 48% increase in GMP manufacturing space despite COVID-19 pandemicPost-Brexit transition guidance for the cell and gene therapy industryPost-Brexit transition guidance for the cell and gene therapy industryRegulatory News - October 2020Regulatory News - October 2020Regulatory News - September 2020Regulatory News - September 2020Press release: CombiGene and CGT Catapult collaboration completes development of quality control analytical assays for clinical production of CombiGene’s AAV-based gene therapy for the treatment of epilepsyPress release: CombiGene and CGT Catapult collaboration completes development of quality control analytical assays for clinical production of CombiGene’s AAV-based gene therapy for the treatment of epilepsyRegulatory news - August 2020Regulatory news - August 2020